Key result
MTHFR C677T TT genotype is linked to ~99% higher aspirin resistance risk in young CHD patients.
Why the study?
The correlation of the MTHFR C677T TT genotype and T allele with aspirin resistance in young patients with coronary heart disease needed to be investigated and a predictive nomogram model constructed.
Does the MTHFR C677T TT genotype and T allele increase the risk of laboratory-verified aspirin resistance in young patients with coronary heart disease receiving oral aspirin monotherapy?
Cohort (n=150)
No
Does the MTHFR C677T TT genotype and T allele increase the risk of laboratory-verified aspirin resistance in young patients with coronary heart disease receiving oral aspirin monotherapy?
In young patients with coronary heart disease, the MTHFR C677T TT genotype and T allele are independently associated with an increased risk of aspirin resistance, and a nomogram integrating these genetic markers with diabetes, hyperhomocysteinemia, and platelet aggregation rate accurately predicts aspirin resistance (AUC 0.885).
Answers are grounded in this paper and cite their sources.
Does not support routine MTHFR genotyping to guide aspirin therapy; leaves open prospective validation of the nomogram.
Objective: To investigate the correlation between Methylenetetrahydrofolate Reductase (MTHFR) C677T TT genotype and T allele with aspirin resistance (AR) in young patients with coronary heart disease and to construct a predictive nomogram model.Methods: The clinical data of 150 young patients with coronary heart disease (CHD) admitted to Pingliang People's Hospital from August 2022 to August 2024 were retrospectively analyzed.All patients received aspirin antiplatelet therapy, and they were divided into AR group (n=35) and aspirin sensitive (AS) group (n=115) according to aspirin response.MTHFR C677T polymorphism and incidence of AR in young CHD patients were analyzed.The risk factors of AR in young CHD patients were analyzed by univariate and multivariate logistic regression analyses.The incidence of AR in patients with different genotypes and alleles was compared, and a nomogram model for AR in young patients with CHD was constructed and verified.Results: The results of univariate and multivariate logistic analysis showed that diabetes, hyperhomocysteinemia (HHcy), TT genotype, T allele and platelet aggregation rate were the risk factors, while CC genotype was protective factor, for AR in young patients with CHD (P<0.05).TT carriers had higher LDL-C, platelet aggregation rate and AR rate (P<0.001).The nomogram had a consistency index (C-index) of 0.885, an area under the curve (AUC) of 0.885 (95% confidence interval [CI]: 0.822-0.947).Bootstrap internal validation with 1000 resamples confirmed the model maintained stable discrimination and calibration performance in the validation cohort with minor index attenuation.Conclusion: The occurrence of AR in young coronary heart disease patients is related to the MTHFR C677T gene.TT genotype and T allele may increase the risk of AR in patients.Constructing a nomogram model based on MTHFR C677T gene and combined with other key indicators, has predictive value for AR occurrence.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) conducted a cohort in Young patients with coronary heart disease receiving single oral aspirin antiplatelet therapy (n=150). MTHFR C677T TT genotype vs. MTHFR C677T CC and CT genotypes was evaluated on Laboratory-verified aspirin resistance (defined as arachidonic acid inhibition rate <50% after 2 weeks of standardized aspirin therapy) (OR 1.994, 95% CI 1.132-3.513, p=0.017). MTHFR C677T TT genotype was independently associated with increased aspirin resistance risk in young CHD patients, and the predictive nomogram achieved an AUC of 0.885.
Synapse has enriched 10 related papers. Consider them for comparative context: